Inflammatory Diseases

Association between Epstein-Barr virus, inflammatory diseases of mouth

harminka — Tue, 11 Nov 2008 08:07:07 -0600

Researchers at Oregon Health & Science University's School of Dentistry have found that a significant percentage of dental patients with the inflammatory diseases irreversible pulpitis and apical periodontitis also have the Epstein-Barr virus.

Medicaid policies vary widely for rheumatoid arthritis drugs

harminka — Wed, 05 Nov 2008 07:37:58 -0600

Patients with inflammatory diseases such as rheumatoid arthritis now have many more treatment options than in the past, including biologic disease-modifying antirheumatic drugs (DMARDs).

Scientists shine new light on inflammatory diseases

harminka — Mon, 17 Mar 2008 07:58:54 -0500

Investigators at Hospital for Special Surgery have identified a new mechanism involved in the pathogenesis of inflammatory diseases such as rheumatoid arthritis. The mechanism may also shed some light on why gene therapy experiments that use adenoviruses to deliver genes to humans have run into problems. The study will appear online on March 16 in the journal Nature Immunology.

New protein family implicated in inflammatory diseases

harminka — Mon, 10 Mar 2008 10:24:24 -0500

A University of Central Florida research team has discovered a new protein family that may play an important role in preventing inflammatory diseases such as arthritis, some forms of cancer and even heart disease.

'Electronic switch' opens doors in rheumatoid joints

harminka — Wed, 02 Jan 2008 15:04:48 -0600

A breakthrough in understanding the way atoms move across cell membranes in the human body could pave the way for the development of new treatments for inflammatory diseases such as rheumatoid arthritis.

Powerful tool to study the genetics of inflammation

harminka — Sat, 01 Dec 2007 12:35:34 -0600

Scientists have known which genes are linked to inflammation, but now researchers at Wake Forest University Baptist Medical Center have organized this information to develop a powerful tool to aid investigators in studying the genetics of inflammatory diseases.

Potential drug targets in autoinflammatory disease

harminka — Tue, 13 Nov 2007 08:55:41 -0600

Molecular biologists at Jefferson’s Kimmel Cancer Center in Philadelphia have detailed the cascade of cellular events behind some potentially dangerous autoinflammatory diseases. In doing so, they not only have gained a greater understanding of the disease process, but have also identified new potential drug targets for diseases ranging from arthritis to cancer.

Potential new way of treating inflammatory diseases identified

harminka — Fri, 14 Sep 2007 12:46:09 -0500

Scientists have shown for the first time that platelets, the cells needed for blood clotting, help white blood cells called neutrophils fight inflammation. The discovery was made by Ralph Kettritz, Professor of Medicine at the Medical Faculty of the Charite and investigator at the Max Delbrueck Center for Molecular Medicine, Berlin, Germany, and colleagues.

Mucins stand guard against gut infections

harminka — Fri, 20 Jul 2007 03:57:28 -0500

Mucins are large proteins that are secreted on the surface of the gut, and while long regarded as having a role as a barrier to mucosal infection, data to support this theory have been lacking.

Potential role for retinoic acid in autoimmune, inflammatory diseases

harminka — Wed, 20 Jun 2007 07:45:40 -0500

An important finding, which could eventually lead to a new therapeutic approach for treating autoimmune and inflammatory diseases such as rheumatoid arthritis, colitis, psoriasis and others, was announced today by researchers at the La Jolla Institute for Allergy & Immunology (LIAI).

EntreMed Presents Preclinical Data for MKC-1 in Hematological Cancers

Anastvatz — Thu, 19 Apr 2007 06:31:54 -0500

EntreMed, Inc.(Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced the presentation of preclinical results for MKC-1, its novel cell cycle inhibitor. The data were presented by EntreMed scientists at the American Association for Cancer Research (AACR) Annual Meeting being held this week in Los Angeles, California.